Screening clopidogrel non-responders and optimizing antiplatelet therapy after acute and elective percutaneous coronary intervention

被引：0
|
作者：
Lee, S. [1 ]
Vargova, K. [2 ]
Hizoh, I. [2 ]
Gulacsi-Bardos, P. [1 ]
Horvath, Z. S. [1 ]
Kovacs, A. [1 ]
Toth-Zsamboki, E. [2 ]
Preda, I. [2 ]
Kiss, R. G. [2 ]
机构：
[1] Hungarian Acad Sci, Res Grp Inflammat Biol & Immunogen, Budapest, Hungary
[2] State Hlth Ctr, Dept Cardiol, Budapest, Hungary
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：419 / 419
页数：1
相关论文
共 50 条
  • [21] Antiplatelet Therapy for Patients with Hemophilia after Percutaneous Coronary Intervention
    Xie, Peter
    Malik, Devin
    Kuriakose, Philip
    BLOOD, 2018, 132
  • [22] Triple antiplatelet therapy decreases clopidogrel resistance in patients undergoing percutaneous coronary intervention
    Kim, W. J.
    Park, D. W.
    Lee, S. W.
    Kim, Y. K.
    Hong, M. K.
    Kim, J. J.
    Park, S. W.
    Park, S. J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8B): : 95C - 96C
  • [23] Effect of ticagrelor and clopidogrel dual antiplatelet therapy on MPVLR, MAADP, and AA inhibition rate in acute coronary syndrome patients after percutaneous coronary intervention
    Gao, Song-Tao
    Wang, Yu
    Ma, Lei
    MEDICINE, 2023, 102 (37) : E34974
  • [24] Ticagrelor Versus Clopidogrel in Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention for Acute Coronary Syndrome in Chronic Kidney Disease
    Tan, Min Choon
    Vignarajah, Aravinthan
    Winson, Tanusha
    Yeo, Yong Hao
    Ang, Qi Xuan
    Ibrahim, Ramzi
    Lee, Justin Z.
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 244 : 1 - 2
  • [25] Considerations in patients receiving oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention
    Roffman, David S.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (15) : S18 - S24
  • [26] Dual antiplatelet therapy after acute coronary syndrome or percutaneous coronary intervention: with what and for how long?
    Darius, Harald
    INTERNIST, 2021, 62 (11): : 1243 - 1252
  • [27] Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement
    Müller, I
    Besta, F
    Schulz, C
    Massberg, S
    Schönig, A
    Gawaz, M
    THROMBOSIS AND HAEMOSTASIS, 2003, 89 (05) : 783 - 787
  • [28] The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
    Tereshchenko, Andrei S.
    Merkulov, Evgeny, V
    Samko, Anatoly N.
    Abugov, Sergey A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (02) : 277 - 281
  • [29] Antiplatelet Therapy and Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome and Thrombocytopenia
    Yusuf, Syed Wamique
    Iliescu, Cezar
    Bathina, Jaya D.
    Daher, Iyad N.
    Durand, Jean-Bernard
    TEXAS HEART INSTITUTE JOURNAL, 2010, 37 (03) : 336 - 340
  • [30] Controversies of oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention
    Rajagopal, V
    Bhatt, DL
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (06): : 649 - 655
12345